| 000 | 01236na a2200229 4500 | ||
|---|---|---|---|
| 003 | H12O | ||
| 005 | 20180417112242.0 | ||
| 008 | 130622s2012 xxx||||| |||| 00| 0 eng d | ||
| 040 | _cH12O | ||
| 041 | _aeng | ||
| 100 |
_9539 _aRuilope Urioste, Luis Miguel _eNefrología |
||
| 245 | 0 | 0 |
_aPrevention of microalbuminuria in patients with type 2 diabetes and hypertension _h[artículo] |
| 260 |
_bJournal of Hypertension, _c2012 |
||
| 300 | _a30(4):811-818 | ||
| 500 | _aFormato Vancouver: Menne J, Izzo JL Jr, Ito S, Januszewicz A, Katayama S, Chatzykirkou C, et al. Prevention of microalbuminuria in patients with type 2 diabetes and hypertension. J Hypertens. 2012;30(4):811-8. | ||
| 501 | _aPMID: 22418908 | ||
| 504 | _aContiene 31 referencias | ||
| 520 | _aBACKGROUND: We have previously demonstrated in the Randomized Olmesartan and Diabetes Microalbuminuria Prevention study that the angiotensin receptor blocker (ARB) olmesartan delays the onset of microalbuminuria in patients with type 2 diabetes. Now, we investigated the effect in the subpopulation with hypertension. | ||
| 710 |
_986 _aServicio de Nefrología |
||
| 856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/2/pc2067.pdf _ySolicitar documento |
||
| 942 |
_n0 _2ddc _cART |
||
| 999 |
_c2067 _d2067 |
||